基于深度强化学习的冠状动脉药物释放支架中药物扩散的优化
Ziyi Lou1, Jing Zhu1, Ying Wang1
1School of Mathematics and Physics, University of Science and Technology Beijing, Beijing 100083, China.
International journal of pharmaceutics
|March 3, 2026
概括
这项研究引入了深度强化学习 (DRL) 框架,以优化药物释放支架 (DES) 中的药物扩散. 该DRL剂成功增强了不同支架配置的治疗药物输送和统一性.
科学领域:
- 生物医学工程 生物医学工程
- 计算科学 计算科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 药物排泄支架 (DES) 对于治疗冠状动脉疾病至关重要,但优化药物输送仍然是一个挑战.
- 目前的方法在适应性,实时控制药物度和统一性方面扎,特别是在复杂的场景中.
研究的目的:
- 开发和评估深度强化学习 (DRL) 框架,以优化DES中的药物扩散.
- 为了实现药物输送的自适应性,闭环调节,平衡治疗和非治疗水平.
主要方法:
- 将神经网络与基于DRL的框架的近距离政策优化 (PPO) 算法集成.
- 在三个支架配置的系统评估:半嵌入式,完全嵌入式和非嵌入式.
- 实时,反驱动的调节证明了对干扰的稳定性.
主要成果:
- DRL代理对每个配置进行了调整控制策略,提高了整体性能.
- 观察到的显著改善:治疗度增加6.99% (半嵌入式),均度增加8.14% (完全嵌入式),度和均度增加 (非嵌入式).
- 证明了平衡治疗度和均性的能力,同时管理非治疗领域水平.
结论:
- 深度强化学习 (DRL) 提供了一种可行的方法,用于药物释放支架 (DES) 的自适应优化.
- 该框架显示了患者特定应用的潜力,并指导了对支架配置的临床决策.
- 突出了DRL在医疗器械设计中解决复杂,非线性优化问题的能力.
更多相关视频
06:39Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
Published on: February 19, 2020
6.1K
05:04Implantation of Human-Sized Coronary Stents into Rat Abdominal Aorta Using a Trans-Femoral Access
Published on: November 19, 2020
4.0K
相关概念视频
Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Drug Delivery: Overview
1.3K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.3K
Modified-Release Drug Delivery Systems: Stimuli-Activated
184
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
184
Coronary Artery Disease V: Interprofessional Care
450
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
